Nanoscaled metal-organic frameworks: charting a transformative path for cancer therapeutics and beyond
Drug Delivery and Translational Research · 2024
DOI: 10.1007/s13346-024-01622-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, 2024. Verfasst von Catalina Biglione und 2 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Porous Materials Unit, IMDEA Energy Institute, Av. Ramón de la Sagra 3, 28935, Madrid, Spain. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Through this inspirational note, we would like to highlight the potential of nanoscaled metal-organic frameworks within the biomedical field. The unique properties of these materials that make them promising candidates for new nanomedicines are assessed here as well as the progression reached so far for combinational cancer therapies and theranostic, along with its most recent advances in nanomedicine. Finally, the perspective and challenges of these materials within this field is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Porous Materials Unit, IMDEA Energy Institute, Av. Ramón de la Sagra 3, 28935, Madrid, Spain.
ORCID-Profile: Patricia Horcajada
Zitieren
APA
Biglione, C., Hidalgo, T., & Horcajada, P. (2024). Nanoscaled metal-organic frameworks: charting a transformative path for cancer therapeutics and beyond. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01622-w
Vancouver
Biglione C, Hidalgo T, Horcajada P. Nanoscaled metal-organic frameworks: charting a transformative path for cancer therapeutics and beyond. Drug Delivery and Translational Research. 2024. doi:10.1007/s13346-024-01622-w
BibTeX
@article{Biglione2024,
author = {Biglione, Catalina and Hidalgo, Tania and Horcajada, Patricia},
title = {Nanoscaled metal-organic frameworks: charting a transformative path for cancer therapeutics and beyond},
journal = {Drug Delivery and Translational Research},
year = {2024},
doi = {10.1007/s13346-024-01622-w}
}
EUVIMED